308 related articles for article (PubMed ID: 31571712)
1. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
Dakhale GN; Sharma VS; Thakre MN; Kalikar M
Indian J Pharmacol; 2019; 51(4):255-262. PubMed ID: 31571712
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Bidabadi E; Mashouf M
Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910
[TBL] [Abstract][Full Text] [Related]
3. Sodium Valproate versus Propranolol in paediatric migraine prophylaxis.
Ashrafi MR; Shabanian R; Zamani GR; Mahfelati F
Eur J Paediatr Neurol; 2005; 9(5):333-8. PubMed ID: 16120482
[TBL] [Abstract][Full Text] [Related]
4. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
Linde M; Mulleners WM; Chronicle EP; McCrory DC
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010611. PubMed ID: 23797677
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
Ashtari F; Shaygannejad V; Akbari M
Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
[TBL] [Abstract][Full Text] [Related]
6. [Sodium valproate versus propranolol in the prophylactic treatment of migraine].
Kozubski W; Prusiński A
Neurol Neurochir Pol; 1995; 29(6):937-47. PubMed ID: 8714731
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Chart Review of Intravenous Valproate Sodium as a Preventive Treatment for Patients With Chronic Migraine.
Riggins N; Ehrlich A; Sawhney H; Dapkus L; Levin M
Headache; 2020 Mar; 60(3):617-620. PubMed ID: 31985052
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
Afshari D; Rafizadeh S; Rezaei M
Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578
[TBL] [Abstract][Full Text] [Related]
9. Sodium valproate prophylaxis in childhood migraine.
Serdaroglu G; Erhan E; Tekgul H; Oksel F; Erermis S; Uyar M; Tutuncuoglu S
Headache; 2002 Sep; 42(8):819-22. PubMed ID: 12390647
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of magnesium oxide and sodium valproate in prevention of migraine headache: a randomized, controlled, double-blind, crossover study.
Karimi N; Razian A; Heidari M
Acta Neurol Belg; 2021 Feb; 121(1):167-173. PubMed ID: 30798472
[TBL] [Abstract][Full Text] [Related]
12. The effects of cinnarizine versus sodium valproate in migraine prophylaxis.
Bostani A; Rajabi A; Moradian N; Razazian N; Rezaei M
Int J Neurosci; 2013 Jul; 123(7):487-93. PubMed ID: 23311688
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial.
Khani S; Hejazi SA; Yaghoubi M; Sharifipour E
J Headache Pain; 2021 Apr; 22(1):21. PubMed ID: 33827421
[TBL] [Abstract][Full Text] [Related]
14. Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up.
Maggioni F; Ruffatti S; Dainese F; Mainardi F; Zanchin G
J Headache Pain; 2005 Sep; 6(4):322-4. PubMed ID: 16362700
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open-label study.
Kinze S; Clauss M; Reuter U; Wolf T; Dreier JP; Einhäupl KM; Arnold G
Headache; 2001 Sep; 41(8):774-8. PubMed ID: 11576201
[TBL] [Abstract][Full Text] [Related]
16. Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study.
Hesami O; Sistanizad M; Asadollahzade E; Johari MS; Beladi-Moghadam N; Mazhabdar-Ghashghai H
Clin Neuropharmacol; 2018; 41(3):94-97. PubMed ID: 29746282
[TBL] [Abstract][Full Text] [Related]
17. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study.
Jensen R; Brinck T; Olesen J
Neurology; 1994 Apr; 44(4):647-51. PubMed ID: 8164818
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol.
Togha M; Malamiri RA; Rashidi-Ranjbar N; Asa S; Mahvelati F; Ashrafi MR
Acta Neurol Belg; 2012 Mar; 112(1):51-5. PubMed ID: 22427290
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
Waberzinek G; Marková J; Mastík J
Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725
[TBL] [Abstract][Full Text] [Related]
20. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
